PATEL DINESH V PH D 4
4 · Protagonist Therapeutics, Inc · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Protagonist Therapeutics (PTGX) CEO Dinesh Patel Gifts 1,460 Shares
What Happened Dinesh V. Patel, Ph.D., President, CEO and Director of Protagonist Therapeutics (PTGX), reported a gift disposition of 1,460 common shares on 2026-04-23. The filing shows the shares were transferred as a bona fide gift (transaction code G) with a reported price of $0.00 and aggregate value $0.
Key Details
- Transaction date: 2026-04-23; Filing date: 2026-04-24 (timely filing).
- Transaction type/code: Gift (G); reported as a disposal (no cash proceeds).
- Shares disposed: 1,460; reported price per share: $0.00; total reported value: $0.
- Footnote: F1 — the transaction involves a bona fide gift of securities to family and friends.
- Shares owned after transaction: Not specified in the provided filing details.
Context Gifts are transfers for personal reasons (to family/friends) and do not necessarily reflect the insider’s view of the company’s prospects. This was not a sale or purchase; it’s a non‑market transfer reported for disclosure and compliance.
Insider Transaction Report
Form 4
PATEL DINESH V PH D
DirectorPresident and CEO
Transactions
- Gift
Common Stock
[F1]2026-04-23−1,460→ 523,478 total
Footnotes (1)
- [F1]This transaction involves a bona fide gift of securities from the Reporting Person to family and friends.
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.|2026-04-24